<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>652</number>
    <updateDate>2026-01-08T20:08:29Z</updateDate>
    <updateDateIncludingText>2026-01-08T20:08:29Z</updateDateIncludingText>
    <originChamber>Senate</originChamber>
    <originChamberCode>S</originChamberCode>
    <type>S</type>
    <introducedDate>2025-02-20</introducedDate>
    <congress>119</congress>
    <legislationUrl>https://www.congress.gov/bill/119th-congress/senate-bill/652</legislationUrl>
    <committees>
      <item>
        <systemCode>sshr00</systemCode>
        <name>Health, Education, Labor, and Pensions Committee</name>
        <chamber>Senate</chamber>
        <type>Standing</type>
        <activities>
          <item>
            <name>Referred To</name>
            <date>2025-02-20T18:11:41Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <actions>
      <item>
        <actionDate>2025-02-20</actionDate>
        <committees>
          <item>
            <systemCode>sshr00</systemCode>
            <name>Health, Education, Labor, and Pensions Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1129-1130)</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2025-02-20</actionDate>
        <text>Introduced in Senate</text>
        <type>IntroReferral</type>
        <actionCode>10000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>D000563</bioguideId>
        <fullName>Sen. Durbin, Richard J. [D-IL]</fullName>
        <firstName>Richard</firstName>
        <lastName>Durbin</lastName>
        <party>D</party>
        <state>IL</state>
        <middleName>J.</middleName>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>M001198</bioguideId>
        <fullName>Sen. Marshall, Roger [R-KS]</fullName>
        <firstName>Roger</firstName>
        <lastName>Marshall</lastName>
        <party>R</party>
        <state>KS</state>
        <sponsorshipDate>2025-02-20</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2025-07-10T15:43:54Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2025-07-10T15:43:41Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2025-07-10T15:44:18Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2025-07-10T15:43:59Z</updateDate>
        </item>
        <item>
          <name>Government information and archives</name>
          <updateDate>2025-07-10T15:44:10Z</updateDate>
        </item>
        <item>
          <name>Health technology, devices, supplies</name>
          <updateDate>2025-07-10T15:44:04Z</updateDate>
        </item>
        <item>
          <name>Internet, web applications, social media</name>
          <updateDate>2025-07-10T15:43:31Z</updateDate>
        </item>
        <item>
          <name>Manufacturing</name>
          <updateDate>2025-07-10T15:44:14Z</updateDate>
        </item>
        <item>
          <name>Marketing and advertising</name>
          <updateDate>2025-07-10T15:43:36Z</updateDate>
        </item>
        <item>
          <name>Prescription drugs</name>
          <updateDate>2025-07-10T15:43:26Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2025-03-13T15:21:07Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2025-02-20</actionDate>
        <actionDesc>Introduced in Senate</actionDesc>
        <updateDate>2026-01-08T20:04:08Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Protecting Patients from Deceptive Drug Ads Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill establishes civil penalties for false or misleading communications about prescription drugs by certain entities on social media. It also requires additional disclosures and reporting relating to drug advertisements on social media or via telehealth.&lt;/p&gt;&lt;p&gt;The billâ€™s civil penalties apply when social media influencers or health care providers make communications regarding prescription drugs, using social media platforms, from which they financially benefit that (1) are made knowingly or recklessly and are&amp;nbsp;false or inaccurate, or (2) fail to include the brief summary information (i.e., side effects, contraindications, effectiveness) required in drug advertisements.&amp;nbsp;The Food and Drug Administration (FDA) must issue guidance and publish notice of such enforcement actions. The FDA may notify drug manufacturers when such communications fail to include the brief summary information.&lt;/p&gt;&lt;p&gt;The bill also requires&amp;nbsp;telehealth providers (i.e., entities that use telecommunications to bring together patients and drug prescribers or dispensers) to include the brief summary information in prescription drug advertisements.&lt;/p&gt;&lt;p&gt;Also, payments from drug manufacturers to health care providers or social media influencers, or from health care providers to influencers, for communications promoting prescription drugs must be reported in accordance with anti-kickback laws for federal health care programs.&lt;/p&gt;&lt;p&gt;Additionally,&amp;nbsp;the FDA may conduct market surveillance regarding prescription drug promotion on social media, including analyzing communications and establishing a task force with the Federal Trade Commission.&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Protecting Patients from Deceptive Drug Ads Act</title>
    <titles>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Protecting Patients from Deceptive Drug Ads Act</title>
        <updateDate>2025-03-13T01:23:24Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Protecting Patients from Deceptive Drug Ads Act</title>
        <updateDate>2025-03-13T01:23:20Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>A bill to provide for the regulation of certain communications regarding prescription drugs.</title>
        <updateDate>2025-03-13T01:18:36Z</updateDate>
        <billTextVersionName>Introduced in Senate</billTextVersionName>
        <billTextVersionCode>IS</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Introduced in Senate</type>
        <date>2025-02-20T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-119s652is/xml/BILLS-119s652is.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2025-02-20</actionDate>
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S1129-1130)</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
